IAPP and type 2 diabetes mellitus: When the potential therapeutic use of FeTPPS in type 2 diabetes to improve the pancreatic β-cell dysfunction was explored, this metalloporphyrin significantly attenuated the cytotoxicity induced by human islet amyloid polypeptide (hIAPP) in a dose-dependent mode [19].